359 related articles for article (PubMed ID: 10525206)
1. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
Stump DG; Holson JF; Fleeman TL; Nemec MD; Farr CH
Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206
[TBL] [Abstract][Full Text] [Related]
2. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
Golub MS; Macintosh MS; Baumrind N
J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328
[TBL] [Abstract][Full Text] [Related]
3. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model.
Hill DS; Wlodarczyk BJ; Finnell RH
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):40-7. PubMed ID: 18186108
[TBL] [Abstract][Full Text] [Related]
4. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
Wlodarczyk B; Spiegelstein O; Gelineau-van Waes J; Vorce RL; Lu X; Le CX; Finnell RH
Toxicol Appl Pharmacol; 2001 Dec; 177(3):238-46. PubMed ID: 11749123
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with periodate-oxidized adenosine enhances developmental toxicity of inorganic arsenic in mice.
Lammon CA; Le XC; Hood RD
Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):335-43. PubMed ID: 14666996
[TBL] [Abstract][Full Text] [Related]
6. Prenatal effects of oral versus intraperitoneal sodium arsenate in mice.
Hood RD; Thacker GT; Patterson BL; Szczech GM
J Environ Pathol Toxicol; 1978; 1(6):857-64. PubMed ID: 731182
[No Abstract] [Full Text] [Related]
7. Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats.
Holson JF; Stump DG; Clevidence KJ; Knapp JF; Farr CH
Food Chem Toxicol; 2000 May; 38(5):459-66. PubMed ID: 10762732
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity of sodium arsenate in rats.
Beaudoin AR
Teratology; 1974 Oct; 10(2):153-7. PubMed ID: 4428424
[No Abstract] [Full Text] [Related]
9. Reproductive and developmental toxicity of arsenic in rodents: a review.
Wang A; Holladay SD; Wolf DC; Ahmed SA; Robertson JL
Int J Toxicol; 2006; 25(5):319-31. PubMed ID: 16940004
[TBL] [Abstract][Full Text] [Related]
10. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
Irvine L; Boyer IJ; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):53-68. PubMed ID: 16496296
[TBL] [Abstract][Full Text] [Related]
11. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
12. Fetotoxicity caused by the interaction between zinc and arsenic in mice.
Fascineli ML; Hunter ES; De Grava Kempinas W
Teratog Carcinog Mutagen; 2002; 22(5):315-27. PubMed ID: 12210494
[TBL] [Abstract][Full Text] [Related]
13. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration.
Hood RD; Vedel-Macrander GC; Zaworotko MJ; Tatum FM; Meeks RG
Teratology; 1987 Feb; 35(1):19-25. PubMed ID: 3563933
[TBL] [Abstract][Full Text] [Related]
14. Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture.
Chaineau E; Binet S; Pol D; Chatellier G; Meininger V
Teratology; 1990 Jan; 41(1):105-12. PubMed ID: 2305370
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.
Holson JF; Desesso JM; Jacobson CF; Farr CH
Teratology; 2000 Jul; 62(1):51-71. PubMed ID: 10861633
[TBL] [Abstract][Full Text] [Related]
17. The role of maternal toxicity in lovastatin-induced developmental toxicity.
Lankas GR; Cukierski MA; Wise LD
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
[TBL] [Abstract][Full Text] [Related]
19. Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice.
Afshar M; Moallem SA; Houshang Mohammadpour A; Shiravi A; Majid Jalalian S; Jafar Golalipour M
Cutan Ocul Toxicol; 2010 Mar; 29(1):10-5. PubMed ID: 19895254
[TBL] [Abstract][Full Text] [Related]
20. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
